These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 19409931)
1. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Sharma M; Anderson SA; Schoop R; Hudson JB Antiviral Res; 2009 Aug; 83(2):165-70. PubMed ID: 19409931 [TBL] [Abstract][Full Text] [Related]
2. Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): dual actions against respiratory bacteria. Sharma SM; Anderson M; Schoop SR; Hudson JB Phytomedicine; 2010 Jul; 17(8-9):563-8. PubMed ID: 20036523 [TBL] [Abstract][Full Text] [Related]
3. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Sharma M; Arnason JT; Burt A; Hudson JB Phytother Res; 2006 Feb; 20(2):147-52. PubMed ID: 16444669 [TBL] [Abstract][Full Text] [Related]
4. Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells. Sharma M; Arnason JT; Hudson JB Phytother Res; 2006 Dec; 20(12):1074-9. PubMed ID: 17009208 [TBL] [Abstract][Full Text] [Related]
5. Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Sharma M; Schoop R; Hudson JB Phytother Res; 2009 Jun; 23(6):863-7. PubMed ID: 19107735 [TBL] [Abstract][Full Text] [Related]
6. Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days. Senchina DS; McCann DA; Asp JM; Johnson JA; Cunnick JE; Kaiser MS; Kohut ML Clin Chim Acta; 2005 May; 355(1-2):67-82. PubMed ID: 15820480 [TBL] [Abstract][Full Text] [Related]
7. The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation. Sharma M; Schoop R; Suter A; Hudson JB Phytother Res; 2011 Apr; 25(4):517-21. PubMed ID: 20830697 [TBL] [Abstract][Full Text] [Related]
8. Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts. Hwang SA; Dasgupta A; Actor JK Clin Chim Acta; 2004 May; 343(1-2):161-6. PubMed ID: 15115689 [TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I). Binns SE; Hudson J; Merali S; Arnason JT Planta Med; 2002 Sep; 68(9):780-3. PubMed ID: 12357386 [TBL] [Abstract][Full Text] [Related]
10. Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells. Vimalanathan S; Schoop R; Suter A; Hudson J Virus Res; 2017 Apr; 233():51-59. PubMed ID: 28279802 [TBL] [Abstract][Full Text] [Related]
11. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells. Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883 [TBL] [Abstract][Full Text] [Related]
12. Effects of Echinacea extracts on macrophage antiviral activities. Senchina DS; Martin AE; Buss JE; Kohut ML Phytother Res; 2010 Jun; 24(6):810-6. PubMed ID: 20041425 [TBL] [Abstract][Full Text] [Related]
13. Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae). Ooi LS; Wang H; Luk CW; Ooi VE J Ethnopharmacol; 2004 Sep; 94(1):117-22. PubMed ID: 15261971 [TBL] [Abstract][Full Text] [Related]
14. Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination. Senchina DS; Wu L; Flinn GN; Konopka del N; McCoy JA; Widrlechner MP; Wurtele ES; Kohut ML Planta Med; 2006 Oct; 72(13):1207-15. PubMed ID: 17021999 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641 [TBL] [Abstract][Full Text] [Related]
16. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. Barnes J; Anderson LA; Gibbons S; Phillipson JD J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249 [TBL] [Abstract][Full Text] [Related]
17. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Ritchie MR; Gertsch J; Klein P; Schoop R Phytomedicine; 2011 Jul; 18(10):826-31. PubMed ID: 21726792 [TBL] [Abstract][Full Text] [Related]
18. Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases. Hudson JB J Biomed Biotechnol; 2012; 2012():769896. PubMed ID: 22131823 [TBL] [Abstract][Full Text] [Related]
19. Effect of Echinacea augustifolia extract on cell viability and differentiation in mammary epithelial cells. Starvaggi Cucuzza L; Motta M; Accornero P; Baratta M Phytomedicine; 2008 Aug; 15(8):555-62. PubMed ID: 18424103 [TBL] [Abstract][Full Text] [Related]
20. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Pleschka S; Stein M; Schoop R; Hudson JB Virol J; 2009 Nov; 6():197. PubMed ID: 19912623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]